CAR T cell therapy and stem cell transplant are among the most advanced treatment options for blood cancers such as leukemia, lymphoma and multiple myeloma. At City of Hope® Orange County, decades of ...

We look at some of the top companies that are investigating CAR-T therapies in clinical trials for autoimmune diseases.

Forlong Biotechnology, a clinical-stage biotech company focused on developing transformative cytokine therapies for patients with severe unmet needs, today announced that its manufacturing partner, ...

A UAB study published in Immunity reveals that T cells help develop diverse anti-carbohydrate antibodies after early microbial exposure, offering new insights into immune defense, autoimmune disease, ...

Sam Neill never lost his genuine concern for the plight of workers and the oppressed, contempt for racialist politics and distrust of celebrity.

New Northwestern Medicine research published in Nature Communications suggests that a metabolite produced by gut bacteria ...

A study suggests that exhausted T cells may be burning energy too aggressively rather than simply running out of it.

Oncology researchers are actively exploring ways to expand mRNA platforms and develop potential universal cancer vaccines.

Kyverna remains on track to complete the rolling BLA submission for miv-cel in SPS in the fourth quarter of 2026. If approved, miv-cel has the potential to become the first FDA-approved CAR T-cell ...

Cellares secures new funding, partnerships and FDA recognition as it prepares for commercial-scale cell therapy manufacturing.

Almost a third of patients with aggressive lymphoma remained cancer free 10 years after treatment with CAR T-cell therapy. The long-term data indicate that CD19-directed CAR T-cell therapy may cure ...

T-cell exhaustion is a central mechanism limiting the durability of antitumor immunity and the long-term efficacy of cancer immunotherapy. Arising under persistent antigenic stimulation and sustained ...